Please login to the form below

Breast Cancer Now

This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash. ... Checkpoint inhibitor immunotherapy drugs have targeted other tumour types before turning to breast cancer, but now Roche's Tecentriq looks set to

Latest news

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Baroness Delyth Morgan, Chief Executive at UK charity Breast Cancer Now (pictured) said: “This marks a really promising step towards being able to safely offer patients a much shorter course of ... Herceptin remains one of the most important advances
NICE backs two advanced breast cancer drugs after price cuts

Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast
Dismay as NICE turns down first-line use of AZ's Faslodex

AstraZeneca's hopes of expanding the use of its breast cancer therapy Faslodex in the UK look rocky after NICE rejected the drug in draft guidance. ... Baroness Delyth Morgan, chief executive at medical charity Breast Cancer Now, said the verdict was
Novartis claims EU approval for breast cancer drug Kisqali

Novartis claims EU approval for breast cancer drug Kisqali. Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe. ... Novartis can now challenge Pfizer's blockbuster breast cancer drug Ibrance in Europe after gaining approval for its
Clovis rockets on maintenance data in ovarian cancer

their indications into other indications such as breast cancer. ... Another candidate - AbbVie's veliparib - failed two phase III trials in April (in breast and lung cancer) and now looks unlikely to challenge the leaders.

More from news
Approximately 2 fully matching, plus 32 partially matching documents found.

Latest Intelligence

30 women leaders in UK healthcare (part 3)

28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast
Engaging the digital healthcare professional

Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer

Misconception. Reality. Pancreatic cancer is rare [8]. Although the incidence of pancreatic cancer is lower than other common cancers like breast, bowel and lung, pancreatic cancer is the 5. ... Unless substantial improvements are made now, pancreatic

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Scientific Director / Editorial Team Leader: Great salary and benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Account Director: £48, 000 - £60, 000

New Business Director - PR: Competitive Salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Medical Writer: Competitive Salary

Account Manager / Senior Account Manager: 35, 000-40, 000

Production Manager – Healthcare Communications: DOE

Director, Market Access / HEOR - North-West: Negotiable

Medical Writers: Competitive Salary and Benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Associate Editorial Director – Med Comms – London: Salary TBC

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Medical Writers Required – Cheshire: DOE

Medical/ Scientific Director: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Senior Systematic Review Analyst - Oxford: Negotiable

Associate Medical Director: Highly Competitive

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...